Magellan Health to Present at Barclays Pharmacy Benefit Management & Drug Pricing Symposium

SCOTTSDALE, Ariz.--()--Magellan Health, Inc. (NASDAQ: MGLN) announced today that Mostafa Kamal, chief executive officer of Magellan Rx Management, the company’s pharmacy benefit management division, will participate in a panel at the Barclays Pharmacy Benefit Management and Drug Pricing Symposium in New York on Thursday, May 25, 2017. The panel will discuss Innovation in Pharmacy Benefit Management.

About Magellan Health: Magellan Health, Inc. is a leader in managing the fastest growing, most complex areas of health, including special populations, complete pharmacy benefits and other specialty areas of healthcare. Magellan supports innovative ways of accessing better health through technology, while remaining focused on the critical personal relationships that are necessary to achieve a healthy, vibrant life. Magellan's customers include health plans and other managed care organizations, employers, labor unions, various military and governmental agencies and third-party administrators. For more information, visit MagellanHealth.com.

Contacts

Magellan Health, Inc.
Media Contact:
Colleen Flanagan Johnson, 860-507-1923
cefjohnson@magellanhealth.com
or
Investor Contact:
Joe Bogdan, 860-507-1910
jbogdan@magellanhealth.com

Release Summary

Magellan Health to present at Barclays PBM and Drug Pricing Symposium.

Contacts

Magellan Health, Inc.
Media Contact:
Colleen Flanagan Johnson, 860-507-1923
cefjohnson@magellanhealth.com
or
Investor Contact:
Joe Bogdan, 860-507-1910
jbogdan@magellanhealth.com